Atossa Therapeutics
ATOS
#9237
Rank
S$0.13 B
Marketcap
S$1.04
Share price
5.24%
Change (1 day)
-35.51%
Change (1 year)

Atossa Therapeutics (ATOS) - Cash on Hand

Cash on Hand as of June 2025 : S$74.97 Million

According to Atossa Therapeutics's latest financial reports the company has S$74.97 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Atossa Therapeutics - Cash on Hand chart (from 2010 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$96.62 M-17.3%
2023-12-31S$0.11 B-21.41%
2022-12-31S$0.14 B-19.37%
2021-12-31S$0.18 B252.34%
2020-12-31S$52.32 M208.51%
2019-12-31S$16.96 M19.61%
2018-12-31S$14.18 M46.91%
2017-12-31S$9.65 M120.28%
2016-12-31S$4.38 M-16.63%
2015-12-31S$5.25 M-53.2%
2014-12-31S$11.23 M39.79%
2013-12-31S$8.03 M280.87%
2012-12-31S$2.1 M-14.74%
2011-12-31S$2.47 M18636.97%
2010-12-31S$0.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$24.05 B 31,982.55%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$0.77 B 933.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$0.55 B 646.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
S$47.55 M-36.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
S$0.21 B 183.66%๐Ÿ‡บ๐Ÿ‡ธ USA